This Government Contract opportunity from Department Of Veterans Affairs was posted on July 8, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
6505--Tamsulosin Capsules - Exelan Pharmaceuticals
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Department of Veterans Affairs (VA) National Acquisition Center plans to issue a Request for Proposal (RFP) for an unrestricted procurement of Tamsulosin Hydrochloride (HCL) Capsules, intended for use across VA facilities, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a responsible offeror capable of providing a continuous supply of the specified medication, with an initial period of one year plus four optional one-year extensions. The procurement emphasizes strict labeling requirements, including a unique National Drug Code (NDC) assigned to the contractor’s label, which must be the sole label on the product, and specific packaging specifications for safety caps and bottle dimensions to ensure safety and compatibility with existing pharmacy systems. The solicitation is expected to be released electronically around January 7, 2025, with a deadline for responses set for January 21, 2025, and will be available exclusively through SAM.gov, with no paper copies provided. The estimated annual demand for Tamsulosin HCL capsules is approximately 1.4 million bottles of 90 capsules each, with additional requirements for larger bottle sizes (500 or 1000 capsules), reflecting significant procurement volume. The NAICS code associated with this procurement is 325412, indicating pharmaceutical manufacturing. Interested vendors are encouraged to monitor SAM.gov for updates and amendments, and all submissions must be made electronically. The primary point of contact is Contract Specialist Andrew Cazares, who can be reached via email or phone for inquiries. This procurement aims to ensure an uninterrupted supply of this medication to support veteran and federal healthcare operations.
General Info
Contract Value
$0Place of Performance
IL, USASet-Aside
Awardee
EXELAN PHARMACEUTICALS INCAward Issued Date
Documents
1AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
